Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients

Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients

Bibliographic Details
Main Authors: Cameron Mura, Saskia Preissner, Susanne Nahles, Max Heiland, Philip E. Bourne, Robert Preissner
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00689-y

Internet

https://doi.org/10.1038/s41392-021-00689-y

Similar Items